Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 91 results:
Συντάκτης Τίτλος Τύπος [ Έτος(Asc)]
Φίλτρα: Keyword is Hypoglycemic Agents  [Clear All Filters]
2024
Karagiannis, T., Tsapas A., Bekiari E., Toulis K. A., & Nauck M. A. (2024).  A Methodological Framework for Meta-analysis and Clinical Interpretation of Subgroup Data: The Case of Major Adverse Cardiovascular Events With GLP-1 Receptor Agonists and SGLT2 Inhibitors in Type 2 Diabetes.. Diabetes Care. 47(2), 184-192.
2023
Georgianos, P. I., Eleftheriadis T., & Liakopoulos V. (2023).  Combination therapy with an SGLT-2 inhibitor and finerenone in DKD: Are we there yet?. Eur J Clin Invest. 53(2), e13864.
Malandris, K., Papandreou S., Avgerinos I., Karagiannis T., Paschos P., Michailidis T., et al. (2023).  Comparative efficacy of glucose-lowering drugs on liver steatosis as assessed by means of magnetic resonance imaging in patients with type 2 diabetes mellitus: systematic review and network meta-analysis.. Hormones (Athens). 22(4), 655-664.
Liakos, A., Karagiannis T., Avgerinos I., Malandris K., Tsapas A., & Bekiari E. (2023).  Management of type 2 diabetes in the new era.. Hormones (Athens). 22(4), 677-684.
Polyzos, S. A., Frühbeck G., & Kiortsis D. N. (2023).  Peptide Polyagonists for the Treatment of Nonalcoholic Fatty Liver Disease.. Curr Pharm Des. 29(41), 3263-3265.
Karagiannis, T., Bekiari E., & Tsapas A. (2023).  Socioeconomic aspects of incretin-based therapy.. Diabetologia. 66(10), 1859-1868.
2022
Stamati, A., Karagiannis T., Tsapas A., & Christoforidis A. (2022).  Efficacy and safety of ultra-rapid insulin analogues in insulin pumps in patients with Type 1 Diabetes Mellitus: A systematic review and meta-analysis.. Diabetes Res Clin Pract. 193, 110144.
Karagiannis, T., Avgerinos I., Liakos A., Del Prato S., Matthews D. R., Tsapas A., et al. (2022).  Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis.. Diabetologia. 65(8), 1251-1261.
Avgerinos, I., Karagiannis T., Kakotrichi P., Michailidis T., Liakos A., Matthews D. R., et al. (2022).  Sotagliflozin for patients with type 2 diabetes: A systematic review and meta-analysis.. Diabetes Obes Metab. 24(1), 106-114.
2021
Tsapas, A., Karagiannis T., Avgerinos I., Matthews D. R., & Bekiari E. (2021).  Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes.. Ann Intern Med. 174(1), 141.
Avgerinos, I., Manolopoulos A., Michailidis T., Kitsios K., Liakos A., Karagiannis T., et al. (2021).  Comparative efficacy and safety of glucose-lowering drugs as adjunctive therapy for adults with type 1 diabetes: A systematic review and network meta-analysis.. Diabetes Obes Metab. 23(3), 822-831.
Tsapas, A., Karagiannis T., Kakotrichi P., Avgerinos I., Mantsiou C., Tousinas G., et al. (2021).  Comparative efficacy of glucose-lowering medications on body weight and blood pressure in patients with type 2 diabetes: A systematic review and network meta-analysis.. Diabetes Obes Metab. 23(9), 2116-2124.
Tsapas, A., Karagiannis T., Avgerinos I., Liakos A., & Bekiari E. (2021).  GLP-1 receptor agonists for cardiovascular outcomes with and without metformin. A systematic review and meta-analysis of cardiovascular outcomes trials.. Diabetes Res Clin Pract. 177, 108921.
Kyriakidou, A., Koufakis T., Goulis D. G., Vasilopoulos Y., Zebekakis P., & Kotsa K. (2021).  Pharmacogenetics of the Glucagon-like Peptide-1 Receptor Agonist Liraglutide: A Step Towards Personalized Type 2 Diabetes Management.. Curr Pharm Des. 27(8), 1025-1034.
Avgerinos, I., Papanastasiou G., Karagiannis T., Michailidis T., Liakos A., Mainou M., et al. (2021).  Ultra-rapid-acting insulins for adults with diabetes: A systematic review and meta-analysis.. Diabetes Obes Metab. 23(10), 2395-2401.
2020
Tsapas, A., Avgerinos I., Karagiannis T., Malandris K., Manolopoulos A., Andreadis P., et al. (2020).  Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes: A Systematic Review and Network Meta-analysis.. Ann Intern Med. 173(4), 278-286.
Nikolaidis, S., Virgiliou C., Vekiou M., Skari A., Kechagidou A., Gika H., et al. (2020).  Effect of exercise on key pharmacokinetic parameters related to metformin absorption in healthy humans: A pilot study.. Scand J Med Sci Sports. 30(5), 858-864.
Mantsiou, C., Karagiannis T., Kakotrichi P., Malandris K., Avgerinos I., Liakos A., et al. (2020).  Glucagon-like peptide-1 receptor agonists and sodium-glucose co-transporter-2 inhibitors as combination therapy for type 2 diabetes: A systematic review and meta-analysis.. Diabetes Obes Metab. 22(10), 1857-1868.
Liakos, A., Tsapas A., & Bekiari E. (2020).  In type 2 diabetes, SGLT2 inhibitors were linked to diabetic ketoacidosis vs. DPP-4 inhibitors.. Ann Intern Med. 173(12), JC70.
Liakos, A., Tsapas A., & Bekiari E. (2020).  Some glucose-lowering drugs reduce risk for major adverse cardiac events.. Ann Intern Med. 173(2), JC9.
2019
Paschou, S. A., Anagnostis P., Pavlou D. I., Vryonidou A., Goulis D. G., & Lambrinoudaki I. (2019).  Diabetes in Menopause: Risks and Management.. Curr Vasc Pharmacol. 17(6), 556-563.
Pantelidis, P., Tsitsopoulos P. P., Pappa E., Theologou E., Karanikolas N., Drosos C., et al. (2019).  The effect of diabetes mellitus on in-hospital hyperglycemia, length of stay and survival in patients with brain tumor receiving dexamethasone: A descriptive and comparative analysis.. Clin Neurol Neurosurg. 184, 105450.
Piperidou, A., Sarafidis P., Boutou A., Thomopoulos C., Loutradis C., Alexandrou M. Eleni, et al. (2019).  The effect of SGLT-2 inhibitors on albuminuria and proteinuria in diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials.. J Hypertens. 37(7), 1334-1343.
Sarafidis, P., Ferro C. J., Morales E., Ortiz A., Malyszko J., Hojs R., et al. (2019).  SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA.. Nephrol Dial Transplant. 34(2), 208-230.
Georgianos, P. I., Divani M., Eleftheriadis T., Mertens P. R., & Liakopoulos V. (2019).  SGLT-2 inhibitors in Diabetic Kidney Disease: What Lies Behind their Renoprotective Properties?. Curr Med Chem. 26(29), 5564-5578.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές